Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Banlangen Granules Anti-seasonal Influenza Study: a Randomized, Double Blind, Positive and Placebo Controlled，Clinical Study.

NCT02232945 is registered in ClinicalTrials.gov with Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited as lead sponsor.

NCT NCT02232945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02232945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Banlangen Granules Anti-seasonal Influenza Study: a Randomized, Double Blind, Positive and Placebo Controlled，Clinical Study.
Lead sponsor
Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2012
Completion date
November 30, 2016
Enrollment
177 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza